Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
(ShareCast News) - AIM-listed Oxford Pharmascience said its OXPzero pain killer drug has reached the second stage of its clinical trial. In a statemen...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE